SCHEMBL9492233

SCHEMBL9492233

C=CCN1C(=O)C[S+]([O-])/C1=N/N=C1/SCC(=O)N1C

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.39
▸ RECQL P46063 2/20 0.38
▸ MAPT P10636 1/20 0.37
▸ TSHR P16473 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ GAA P10253 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ POLB P06746 2/20 0.32
▸ USP2 O75604 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492241 1.00 LMNA (0.39) LMNARECQLMAPTTSHRMAPK1
SCHEMBL9491952 0.86 LMNA (0.44) LMNARECQLMAPTTSHRMAPK1
SCHEMBL9491949 0.86 LMNA (0.44) LMNARECQLMAPTTSHRMAPK1
SCHEMBL9494278 0.81 LMNA (0.52) LMNARECQLMAPTTSHRMAPK1
SCHEMBL9494274 0.81 LMNA (0.52) LMNARECQLMAPTTSHRMAPK1
SCHEMBL9494856 0.75 LMNA (0.41) LMNARECQLMAPTTSHRMAPK1
SCHEMBL9494860 0.75 LMNA (0.41) LMNARECQLMAPTTSHRMAPK1
Phosphoric Acid SCHEMBL11090384 0.74 LMNA (0.49) LMNARECQLMAPTTSHRMAPK1
SCHEMBL10721434 0.72 LMNA (0.42) LMNARECQLMAPTTSHRMAPK1
SCHEMBL10721429 0.72 LMNA (0.42) LMNARECQLMAPTTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0494047-A1 Use of carbazones for the treatment of rheumatoid diseases CIBA-GEIGY AG (CH) 1992-07-08 — — EP claimed
US-5177091-A Rheumatic disorders CIBA-GEIGY CORPORATION (US) 1993-01-05 — — US disclosed
EP-0494047-A1 Use of carbazones for the treatment of rheumatoid diseases CIBA-GEIGY AG (CH) 1992-07-08 — — EP disclosed
Send feedback